To layoff 5,000 employees by the end of the year; aims to reduce operating expenses by approximately $1.5 billion by 2027.

Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and ...

Marken's Mike Bartone, VP of Global Cold Chain Solutions Management, on scaling temperature-controlled precision logistics, ...

Velocity Clinical Research, an integrated research site organization, has appointed Ines Abs as its new Country Head of ...

Additional clinical sites in the EU will assess HT-001 for the treatment of skin toxicities associated with EGFRi.

David King of Samsung Biologics shares insights on market demand and the technologies and capabilities needed to support ...

Dr. Keith Robinson joins as Chief Medical Officer and Dr. Lonnie Brent has been appointed Senior Vice President of Medical ...

Symbiosis Pharmaceutical Services, a global CMO, has successfully completed its 1,000th sterile drug product batch. The ...

Novo Nordisk has appointed Maziar Mike Doustdar as President and CEO, effective August 7, 2025. Doustdar succeeds Lars ...

Flow Sciences, a global leader in advanced containment solutions, announced the opening of a new office in the Research ...

This platform aims to deliver high-quality cyclic peptides with faster timelines and better economy across a broad range of ...

Evotec SE has signed a non-binding agreement with Sandoz AG regarding the potential sale of Just – Evotec Biologics EU, which ...